Literature DB >> 30482928

Frustrated Alzheimer's researchers seek better lab mice.

Sara Reardon.   

Abstract

Entities:  

Keywords:  Biotechnology; Brain; Neuroscience

Mesh:

Substances:

Year:  2018        PMID: 30482928     DOI: 10.1038/d41586-018-07484-w

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

Review 1.  Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer's Disease.

Authors:  Thuy Trang Nguyen; Tuong Kha Vo; Giau Van Vo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?

Authors:  Jacques Fantini; Henri Chahinian; Nouara Yahi
Journal:  Protein Sci       Date:  2020-07-13       Impact factor: 6.725

3.  Vaccination Prevented Short-Term Memory Loss, but Deteriorated Long-Term Spatial Memory in Alzheimer's Disease Mice, Independent of Amyloid-β Pathology.

Authors:  Klaske Oberman; Leonie Gouweleeuw; Peter Hoogerhout; Ulrich L M Eisel; Elly van Riet; Regien G Schoemaker
Journal:  J Alzheimers Dis Rep       Date:  2020-07-23

Review 4.  Cell Type Specific Expression of Toll-Like Receptors in Human Brains and Implications in Alzheimer's Disease.

Authors:  Henriette R Frederiksen; Henriette Haukedal; Kristine Freude
Journal:  Biomed Res Int       Date:  2019-07-18       Impact factor: 3.411

5.  β-Asarone Inhibits Amyloid-β by Promoting Autophagy in a Cell Model of Alzheimer's Disease.

Authors:  Nanbu Wang; Haoyu Wang; Lingyu Li; Yunchuan Li; Ronghua Zhang
Journal:  Front Pharmacol       Date:  2020-01-17       Impact factor: 5.810

Review 6.  A Pathophysiological Intersection of Diabetes and Alzheimer's Disease.

Authors:  Maša Čater; Sabine M Hölter
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

Review 7.  Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease.

Authors:  Nouara Yahi; Coralie Di Scala; Henri Chahinian; Jacques Fantini
Journal:  Glycoconj J       Date:  2021-07-30       Impact factor: 2.916

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.